The 19 references in paper Aleksandr Markovsky V., А. Марковский В. (2018) “АДДИТИВНЫЙ ЭФФЕКТ ПОЛИМОРФИЗМА ГЕНОВ БЕЛКОВ ФОЛАТНОГО ОБМЕНА И УРОВЕНЬ ГОМОЦИСТЕИНА У БОЛЬНЫХ ПРОЛИФЕРАТИВНЫМИ ЗАБОЛЕВАНИЯМИ МОЛОЧНОЙ ЖЕЛЕЗЫ КАК ПОТЕНЦИАЛЬНЫЙ ФАКТОР РИСКА ТРОМБОЗОВ // ADDITIVE EFFECT OF GENES POLYMORPHISM OF FOLATE CYCLE PROTEINS AND HOMOCYSTEIN LEVEL IN PATIENTS WITH PROLIFERATIVE DISEASES OF THE BREAST AS A POTENTIAL FACTOR OF THE RISK OF THROMBOSSES” / spz:neicon:aterotromboz:y:2018:i:2:p:46-53

1
Brose K.M.J., Lee A.Y.Y. Cancer-associated thrombosis: prevention and treatment. Curr Oncol. 2008; 15(suppl 1): 58–67. PMC2216419.
(check this in PDF content)
2
Horsted F., West J., Grainge M.J. Risk of Venous thromboembolism in Patients with Cancer: A systematic Review and Meta-Analysis. PLoS med. 2012; 9(7): e1001275. doi: 10.1371/journal. p m e d.10 01275.
(check this in PDF content)
3
ouyang s., Li Y., Liu Z. et al. Association between MtR A2756G and MtRR A66G polymorphisms and maternal risk for neural tube defects: a meta-analysis. Gene. 2013; 515(2): 308-12. doi: 10.1016/j.gene.2012.11.070.
(check this in PDF content)
4
Злокачественные новообразования в России в 2016 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «ФМИЦ им. П.А. Герцена» Минздрава России, 2018. 250 с. IsBn 978-5-85502-234-6. / Malignant tumors in Russia in 2016 (incidence and mortality). ed. by A.D. Kaprin, V.V. starinsky, G.V. Petrova. M.: FsU P.A. Herzen MnIoI, branch of FsBU P.A. Herzen FMIZ Health care of Russia, 2018. 250 p. IsBn 978-5-85502-234-6.
(check this in PDF content)
5
Марковский А.В., Страмбовская Н.Н., Терешков П.П. Молекулярно-генетические и сывороточные маркеры нарушений фолатного обмена у больных пролиферативными заболеваниями и раком молочной железы. Сибирский онкологический журнал. 2017; 16(2): 50–55. doi: 10.21294/181448612017-16-2-50-55. / Markovsky A.V., strambovskaya n.n ., tereshkov P.P. Molecular-genetic and serum markers of folate metabolism deficiency in patients with proliferative breast disease and breast cancer. Siberian Journal of Oncology. 2017; 16(2): 50–55. doi: 10.21294/18144861-2017-16-2-50-55.
(check this in PDF content)
6
Khan U.t., Walker A.J., Baig s. et al. Venous thromboembolism and mortality in breast cancer: cohort study with systematic review and meta-analysis. BmC Cancer. 2017; 17(1): 747. doi: 10.1186/s12885-0173719 -1 .
(check this in PDF content)
7
Zhloba A.A., Blashko e.L. Liquid chromatographic determination of total homocysteine in blood plasma with photometric detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2004; 800(1-2): 275-280. PMID: 14698266.
(check this in PDF content)
8
Raijmakers M.t.M., steegers e.A.P., Peters W.H.M. Glutathione s-transferases and thiol concentrations in embryonic and early fetal tissues. Human reproduction. 2001; 16(11): 2445–2450. PMID: 11679536.
(check this in PDF content)
9
Шилова А.Н., Шкода О.С., Ломиворотов В.В. и др. Ассоциация полиморфных вариантов генов метаболизма фолиевой кислоты с риском развития рака легкого, рака предстательной железы, рака молочной железы и рака матки. Российский онкологический журнал. 2017; 22(4): 203-208. doi:
(check this in PDF content)
10
18821/1028-9984-2017-22-4-203-208. / shilova A.n., shkoda o.s., Lomivorotov V.V. et al. Association of the folate metabolism genes with the risk for lung, prostate, breast and uterine cancer. russian Cancer Journal. 2017; 22(4): 203-208. doi: 10.18821/10289984-2017-22-4-203-208. 10. Баркаган З.С., Костюченко Г.И., Котовщикова Е.Ф. Гипергомоцистеинемия как самостоятельный фактор риска поражения и тромбирования кровеносных сосудов. Патология кровообращения и кардиохирургия. 2002; 1: 65–71. / Barkagan Z.s., Kostyuchenko G.I., Kotovshchikova e.F. Hyperhomocysteinemia as independent risk factor of blood vessels lesion and thrombosing. Pathology of circulation and heart surgery. 2002; 1: 65–71.
(check this in PDF content)
11
Foy P., Moll s. thrombophilia: 2009 Update. Curr Treat Options Cardio med. 2009; 11(2): 114-128. https: //doi. org/10.1007/s11936-009-0012-x.
(check this in PDF content)
12
Pasta L., Pasta F., D’Amico M. PAI-1 4G-4G, MtHFR 677tt, V Leiden 506Q, and Prothrombin 20210A in splanchnic Vein thrombosis: Analysis of Individual Patient Data From three Prospective studies. J Clin Exp Hepatol. 2016 Mar; 6(1): 10-4. doi: 10.1016/j. jceh.2015.11.002.
(check this in PDF content)
13
Falvella F.s., Cremolini C., Miceli R. et al. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab. Pharmacogenomics J. 2017; 17(4): 331-336. doi: 10.1038/tpj.2016.22.
(check this in PDF content)
14
Zhao M., Wang X. et al. Homocysteine and stroke Risk: Modifying effect of Methylenetetrahydrofolate Reductase C677t Polymorphism and Folic Acid Intervention. Stroke. 2017; 48(5): 1183–1190. doi: 10.1161/stRoKeAHA.116.015324.
(check this in PDF content)
15
Yates Z., Lucock M. Interaction between common folate polymorphisms and B-vitamin nutritional status modulates homocysteine and risk for a thrombotic event. mol Genet metab. 2003; 79(3): 201-213. doi: https: //doi.org/10.1016/s1096-7192(03)00093-3.
(check this in PDF content)
16
naushad s.M., Jain Jamal M.n., Prasad C.K. Relationship between methionine synthase, methionine synthase reductase genetic polymorphisms and deep vein thrombosis among south Indians. Clin Chem Lab med. 2008; 46(1): 73-79. doi: 10.1515/ CCLM.2008.021.
(check this in PDF content)
17
Harmon D.L., shields D.C., Woodside J.V. et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol. 1999; 17(4): 298-309. doi: 10.1002/(sICI)1098-2272(199911)17: 4<298: : AID-GePI5>3.0.Co, 2-V.
(check this in PDF content)
18
Ray J.G. Hyperhomocysteinemia: no longer a consideration in the management of venous thromboembolism. Curr Opin Pulm med. 2008; 14(5): 369-373. doi: 10.1097/MCP.0b013e328307ee38.
(check this in PDF content)
19
Heijer M., Lewington s., Clarke R. Homocysteine, MtHFR and risk of venous thrombosis a meta-analysis of published epidemiological studies. J Thromb Haemost. 2005; 3: 292-299. doi: 10.1111/j.15387836.2005.01141.x.
(check this in PDF content)